Evidence map›Paper›PMID 42778932›Full record

ArticleHarm reduction journal2026

Relative affordability of heated tobacco products and cigarettes: a cross-country comparative analysis of 55 countries.

Giorgi Mzhavanadze

Abstract readComparative Study
In one paragraph

Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Giorgi MzhavanadzeKnowledge-Action-Change, 5 Heatherfold Way, Pinner, HA5 2LG, UK. giorgi@kachange.eu.ORCID http://orcid.org/0000-0002-0336-311X

Funding

Global Action to End Smoking CONT-004
6 · The paper itself

Abstract

backgroundSince their introduction in 2014, heated tobacco products (HTPs) have entered a growing number of countries. However, few studies have systematically compared their affordability with that of cigarettes or examined differences in access across income groups. This study assessed the affordability of HTPs relative to combustible cigarettes with a focus on socioeconomic disparities.

methodsUsing publicly available data from the World Health Organization, World Bank, and industry sources, we compared retail prices, affordability, and tax shares across 55 countries with complete analytical data. Affordability was measured as the share of GDP per capita required to purchase 100 packs. Income distribution data were used to assess affordability across income quintiles.

resultsHTP sticks were more expensive than the most-sold cigarette brand in 23 countries and more expensive than the cheapest cigarette brand in 44 countries. In all 9 lower-middle-income countries and 10 of 16 upper-middle-income countries, HTPs were more expensive than the most-sold cigarette brand; in 24 of 30 high-income countries, they were cheaper. HTPs were not marketed in low-income countries. In lower-middle-income countries, purchasing 100 packs required 7.9% of GDP per capita for HTP sticks, compared with 5.3% for the most-sold cigarette brand and 3.5% for the cheapest brand. In high-income countries, the corresponding values were 1.6%, 1.9%, and 1.5%, respectively. For the lowest-income quintile across countries, purchasing 100 packs of HTPs required 9.1% of annual income, compared with 7.9% for the most-sold cigarette brand; for the highest-income quintile, the figures were 1.4% and 1.3%. Including device costs increased annual HTP use costs by 9.2-35.3%.

conclusionsHTPs were often less affordable than cigarettes, particularly in lower-income countries and among lower-income population groups. This pattern was not explained by higher taxes on HTP sticks; in most countries, HTPs had lower tax shares than cigarettes, but this did not consistently translate into lower retail prices. Assessments of HTP affordability should therefore consider observed consumer prices, upfront device costs, and within-country income differences, rather than tax rates alone.

Indexed as

CommerceTobacco ProductsCosts and Cost AnalysisDeveloped CountriesDeveloping CountriesHot TemperatureHumansIncomeTaxesAffordabilityCigarettesHarm reductionHeated tobacco productsRelative income priceTobacco control.Tobacco taxation

Identifiers

PMID42778932
PMCPMC13602604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.